A Revolutionary Breakthrough in Autism Research
In a landmark achievement, Iraqi scientist Adel Abdul Rahman Sadeq Al-Salhi has secured a United States patent for a pioneering new treatment targeting Autism Spectrum Disorder (ASD). His discovery heralds a new era of hope for millions of families around the world affected by autism.
Years of Research, A Future of Hope
Dr. Al-Salhi revealed that this breakthrough is the culmination of extensive field and laboratory research spanning several years. He described the treatment as a “scientific and humanitarian revolution,” aiming to offer a tangible change in the lives of children with autism and their families. The patent registration marks the first major step toward bringing this vision into reality.
The Path Forward: Clinical Trials Underway
Currently, Dr. Al-Salhi and his team are preparing to launch experimental protocols on highly sensitive animal models, laying the groundwork for future clinical trials. These studies are being conducted under strict scientific and ethical standards, with collaboration from leading experts in immunology, neurology, and nanophysics.
A Global Achievement, Not Just for Iraq
Dr. Al-Salhi emphasized that this breakthrough extends beyond national pride, positioning Baghdad at the forefront of global scientific research. His achievement places Iraq firmly on the map in the international race to find effective solutions for autism.
Secret Formula with Impressive Results
The new treatment is based on rare, naturally occurring human immune components developed into a proprietary and legally protected formula. Early simulated trials have shown outstanding success rates, ranging from 70% to 86% among children with immune-based forms of autism.
A Vision for the Future
This innovation is part of Dr. Al-Salhi’s broader scientific mission: developing a comprehensive understanding of the biological and environmental causes of autism, and designing preventive therapies to address the disorder’s growing global impact.
Conclusion
The registration of this patent is a major milestone — one that could revolutionize how autism is treated worldwide. As animal and clinical trials move forward, millions of families hold onto a renewed sense of hope for a future where autism is no longer a silent barrier but a challenge that science can overcome.